Skip to main content
Collection

Medicines: clinical trials hub

Legal framework, regulatory requirements, and supporting guidance needed to design, apply for, conduct, modify, close, and comply with UK legislation for clinical trials for medicines in the UK.

Clinical Trial Protocol Checker

Clinical Trial sponsors and their representatives can use this AI-powered tool to check their draft protocols for potential issues that could lead to Requests for Further Information (RFIs) prior to submission.

Checking your protocol saves time during assessment

The tool will check your protocol for possible causes of RFIs in four common clinical areas:

  • Unblinding in case of an emergency
  • Clinical eligibility criteria
  • Contraceptive requirements
  • Adverse event and serious adverse recording and reporting

Checking your protocol for potential issues in these categories and addressing them prior to submission may help reduce the likelihood of them being raised during assessment.

Registration for access to the AI tool is planned to open late November 2026, with a phased approach to onboarding.

Sign up to ‘Get emails about this page’ when more information is available.

UK Legislation

The Medicines for Human Use (Clinical Trials)(Amendment) Regulations 2025 came into force 28 April 2026.

The Medicines for Human Use (Clinical Trials)Regulations 2004

The Medicines for Human Use (Clinical Trials)(Amendment) Regulations 2025

The Human Medicines Regulations 2012

Regulatory Framework

Important Note: This guidance is designed to assist sponsors and investigators in complying with their duties in relation to clinical trials. This page includes links to pages containing general guidance only. It must not be regarded as a definitive interpretation of the Regulations or a substitute for the regulations.

The MHRA cannot provide a definitive interpretation of the law; only the courts can do this. If in doubt you should seek your own legal advice.

International guidance

ICH Efficacy Guidelines

Other relevant guidance

Health Research Authority

MHRA guidance

The amended Clinical Trials Regulations took full effect on 28 April 2026. As such, this guidance should now be considered effective and is no longer in draft.

Applying for clinical trial approval

IMPs & NIMPs

During the clinical trial

Making changes to trials

Ending a trial

Compliance

News and blogs

Payments and fees

Payments for DSUR submissions by credit or debit cards can be made via our payment centre.

Archived guidance

Access previous versions of MHRA Guidance from the UK Government Web Archive

Guidance - before 28 April 2026

Clinical Trials guidance that should be followed prior to 28 April 2026.